Media headlines about MedAssets (NASDAQ:MDAS) have been trending somewhat positive recently, Accern reports. The research firm ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. MedAssets earned a news sentiment score of 0.01 on Accern’s scale. Accern also assigned headlines about the technology company an impact score of 52.3780758796622 out of 100, meaning that recent media coverage is somewhat likely to have an impact on the stock’s share price in the immediate future.
COPYRIGHT VIOLATION NOTICE: “MedAssets (NASDAQ:MDAS) Getting Somewhat Positive Media Coverage, Study Finds” was reported by BNB Daily and is owned by of BNB Daily. If you are viewing this piece of content on another publication, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.baseball-news-blog.com/2017/08/13/somewhat-positive-media-coverage-somewhat-likely-to-impact-medassets-nasdaqmdas-share-price-updated.html.
MedAssets Company Profile
MedAssets, Inc (MedAssets) provides technology-enabled products and services to healthcare organizations, including hospitals, health systems, non-acute healthcare providers, payers, other service providers and product manufacturers. The Company operates its business through two business segments: Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM).
Receive News & Ratings for MedAssets Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedAssets Inc. and related companies with MarketBeat.com's FREE daily email newsletter.